Arcus Biosciences, Inc.·4

Dec 20, 4:06 PM ET

Azoy Alexander 4

4 · Arcus Biosciences, Inc. · Filed Dec 20, 2024

Insider Transaction Report

Form 4
Period: 2024-12-19
Azoy Alexander
Chief Accounting Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2024-12-19$15.17/sh3,007$45,61613,094 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024.

Documents

1 file
  • 4
    wk-form4_1734728787.xmlPrimary

    FORM 4